Flexion Therapeutics Obtains $20,000,000 Series B Funding

  • Feed Type
  • Date
    12/4/2012
  • Company Name
    Flexion Therapeutics
  • Mailing Address
    300 TradeCenter Woburn, MA 01801
  • Company Description
    Flexion Therapeutics advances drug candidates through clinical proof of concept and beyond, in partnership with pharmaceutical and biotechnology companies. By providing expertise and sharing risk, Flexion effectively expands the portfolios of its partners.
  • Website
    http://www.flexiontherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds will be used to fund late stage clinical development of the company’s portfolio of intra-articular, sustained release therapies for the treatment of osteoarthritis.
  • M&A Terms
  • Venture Investor
    Novo A/S
  • Venture Investor
    5AM Ventures
  • Venture Investor
    Pfizer Venture Investments
  • Venture Investor
    Sofinnova Ventures
  • Venture Investor
    Versant Ventures
  • Venture Investor
    Versant Ventures

By posting a comment, you agree to our terms and conditions.